0000899243-18-007529.txt : 20180315
0000899243-18-007529.hdr.sgml : 20180315
20180315160527
ACCESSION NUMBER: 0000899243-18-007529
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180314
FILED AS OF DATE: 20180315
DATE AS OF CHANGE: 20180315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gengos Andrew
CENTRAL INDEX KEY: 0001563623
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37566
FILM NUMBER: 18692400
MAIL ADDRESS:
STREET 1: 21900 BURBANK BOULEVARD
STREET 2: 3RD FLOOR
CITY: WOODLAND HILLS
STATE: CA
ZIP: 91367
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNLOGIC, INC.
CENTRAL INDEX KEY: 0001527599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261824804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-401-9975
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Mirna Therapeutics, Inc.
DATE OF NAME CHANGE: 20110809
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-14
0
0001527599
SYNLOGIC, INC.
SYBX
0001563623
Gengos Andrew
C/O SYNLOGIC, INC.
301 BINNEY STREET, SUITE 402
CAMBRIDGE
MA
02142
0
1
0
0
Chief Operating Officer
Stock Option (right to buy)
9.95
2018-03-14
4
A
0
10000
0.00
A
2028-03-14
Common Stock
10000
10000
D
The options vest and become exercisable in substantially equal monthly installments beginning on April 14, 2018 and continuing until March 14, 2022, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date.
/s/ William J. Bussiere, Jr., Attorney-in-fact
2018-03-15